New Funding Opportunity: SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics Toward Commercialization (R44)
The National Cancer Institute (NCI) has announced a new funding opportunity that aims to accelerate development of novel cancer-related commercial products and technologies. This announcement is soliciting applications from small business concerns seeking additional funding to support projects previously funded by NIH Small Business Innovation Research (SBIR) Phase II awards. This new opportunity was created to foster later stage research and development and help applicants reach subsequent milestones required for commercialization. In order to accomplish this goal, the award strongly encourages partnerships between SBIR Phase II awardees and third-party investors and/or strategic partners.
Proposed projects must be applicable to one of the following areas:
- Cancer Therapeutics
- Cancer Imaging Technologies, Interventional Devices, and In Vivo Diagnostics
- In Vitro and Ex Vivo Cancer Diagnostics and Prognostics
View the complete funding announcement here: http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-12-001.html and further questions can be directed to NCI Scientific/Research Contact Andrew J. Kurtz, Ph.D., email@example.com.
New Funding Opportunity: Advancing Novel Science in Women’s Health Research (ANSWER) (R21)
A new funding opportunity announcement (FOA) has become available sponsoring innovative and interdisciplinary research relating to women’s health and sex/gender differences. The Office of Research on Women’s Health, along with several participating Institutes and Centers, including the National Cancer Institute, initially released this funding opportunity in July, 2010. The FOA will use the NIH Exploratory/Developmental (R21) award mechanism, and direct costs are limited to $275,000 over a two-year period.
Some areas of interest include: diseases and conditions that affect women; prevention, treatment, and treatment outcomes; and health disparities/ differences and diversity. Researchers conducting interdisciplinary research investigating how sex and gender factors affect women’s health are encouraged to apply.
The deadline to submit a new application is October 16, 2012 and the deadline for resubmission applications is November 16, 2012.For more details and information on how to apply, go to http://grants.nih.gov/grants/guide/pa-files/PAS-10-226.html and/or contact the FOA’s NCI Research Contact, Karen Parker, Ph.D, at firstname.lastname@example.org